We have located links that may give you full text access.
Case Reports
Journal Article
Treatment of grey zone lymphoma using the R-CODOX-M/R-IVAC protocol: Two case reports.
Medicine (Baltimore) 2017 September
RATIONALE: We report our experience with 2 patients diagnosed with grey zone lymphoma (GZL). The histopathological characteristics of lymphomatous tissues in these patients ranged between those of diffuse large B-cell lymphoma (DLBCL) and the classical Hodgkin lymphoma.
PATIENT CONCERNS: A 52-year-old female presented to the hospital with a history of lower abdominal pain of metastatic origin for 2 days. She was diagnosed with acute appendicitis and had undergone emergency surgery. A 17-year-old male was admitted to the hospital because of acute left upper abdomen pain.
DIAGNOSES: Both patients are diagnosed of GZL primarily based on histopathology.
INTERVENTIONS: Both patients were treated with R-CODOX-M/R-IVAC regimen for 4 to 6 cycles.
OUTCOMES: The short-term curative effect was complete response; no recurrence was observed as of 32-month follow-up.
LESSONS: R-CODOX-M/IVAC regimen exhibited relatively good curative effect. International Prognostic Index score and lactate dehydrogenase level may correlate with prognosis of these patients.
PATIENT CONCERNS: A 52-year-old female presented to the hospital with a history of lower abdominal pain of metastatic origin for 2 days. She was diagnosed with acute appendicitis and had undergone emergency surgery. A 17-year-old male was admitted to the hospital because of acute left upper abdomen pain.
DIAGNOSES: Both patients are diagnosed of GZL primarily based on histopathology.
INTERVENTIONS: Both patients were treated with R-CODOX-M/R-IVAC regimen for 4 to 6 cycles.
OUTCOMES: The short-term curative effect was complete response; no recurrence was observed as of 32-month follow-up.
LESSONS: R-CODOX-M/IVAC regimen exhibited relatively good curative effect. International Prognostic Index score and lactate dehydrogenase level may correlate with prognosis of these patients.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app